General Information
Revision date
2021-04-02
Product name
Paclitaxel, Anticancer agent Substance
Substance name
Contains Paclitaxel
CAS No.
33069-62-4
1.2.1 Relevant identified uses
For research use only. Not for use in diagnostic procedures
Manufacturer Name
Abcam plc
Emergency telephone
+44 1273 289451
Icons in SDS
Company Information
company name
Abcam plc
e-mail address of the competent person responsible for the Safety Data Sheet
technical@abcam.com, sds@abcam.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H315, H317, H318, H335, H361, H413
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Danger Hazard statements H315 - Causes skin irritation H317 - May cause an allergic skin reaction H318 - Causes serious eye damage H335 - May cause respiratory irritation H361 - Suspected of damaging fertility or the unborn child H413 - May cause long lasting harmful effects to aquatic life Precautionary Statements - EU (§28, 1272/2008) P261 - Avoid breathing dust/fume/gas/mist/vapours/spray P264 - Wash face, hands and any exposed skin thoroughly after handling P305 + P351 + P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing P310 - Immediately call a POISON CENTER or doctor P280 - Wear protective gloves/protective clothing and eye/face protection
2.3 Other hazards
Caution - substance not yet tested completely.
2.1 Classification of the substance or mixture
Regulation (EC) No 1272/2008 Skin corrosion/irritation Category 2 - (H315) Serious eye damage/eye irritation Category 1 - (H318) Skin sensitisation Category 1 - (H317) Reproductive toxicity Category 2 - (H361) Specific target organ toxicity — single exposure Category 3 - (H335) Category 3 Respiratory irritation Chronic aquatic toxicity Category 4 - (H413)
